Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry Study for COVID19 Vaccination Efficacy in Patients With a Treatment History of Rituximab.

NCT04877496 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT04877496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04877496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry Study for COVID19 Vaccination Efficacy in Patients With a Treatment History of Rituximab.
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Unknown status
Start date
April 26, 2021
Completion date
October 31, 2021
Enrollment
425 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19 vaccination, immunosuppression, rituximab